Company Filing History:
Years Active: 2018
Title: Zigmars Andzans: Innovator in Multidrug Resistance Modulation
Introduction
Zigmars Andzans is a notable inventor based in Ogresgals, Latvia. He has made significant contributions to the field of organic synthesis, particularly in the development of compounds that address multidrug resistance in medical treatments. His work is recognized for its potential impact on improving therapeutic efficacy.
Latest Patents
Zigmars Andzans holds a patent for "Thieno [2,3-b] pyridines as multidrug resistance modulators." This patent involves thieno[2,3-b]pyridines of general formula (I), where R can be various chemical groups such as Me, CH, 3,4,5-(OMe)CH, NH, H, CN, COMe, COOCalkyl, COOCHOMe, and COOCHOPr(n). This innovation is crucial for enhancing the effectiveness of drugs against resistant strains of diseases.
Career Highlights
Zigmars Andzans is affiliated with the Latvian Institute of Organic Synthesis, where he conducts his research and development activities. His work at this esteemed institution has allowed him to explore various chemical compounds and their applications in medicine.
Collaborations
Zigmars has collaborated with notable colleagues such as Ivars Kalvins and Aivars Krauze. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their field.
Conclusion
Zigmars Andzans is a prominent figure in the realm of organic synthesis, with a focus on combating multidrug resistance. His contributions through patents and collaborations highlight his commitment to advancing medical science.